s_almutar Profile Banner
Sara Almutar Profile
Sara Almutar

@s_almutar

Followers
2K
Following
835
Media
27
Statuses
239

Glomerulonephritis Fellow 2023 @McMasterU, Canada. @GlomCon fellow 2024. Passionate nephrologist, interested in obstetric nephrology, and glomerular diseases.

Joined December 2013
Don't wanna be here? Send us removal request.
@s_almutar
Sara Almutar
19 hours
RT @GlomCon: 🚨 2 days left to apply for the Glomerular Disease Fellowship. By participating, you'll have the amazing opportunity to learn f….
0
6
0
@s_almutar
Sara Almutar
15 days
RT @edgarvlermamd: Malignancies and glomerulonephritis: when to suspect and when to screen? ca. 2025 from @CKJsocial @AKronbichler @Annette….
0
27
0
@s_almutar
Sara Almutar
22 days
So thrilled and proud to have completed the @GlomCon fellowship!!🎓 Huge thanks for this great opportunity! Truly enjoyed it and learned a lot from the best! Looking forward to future collaborations!! .#GlomCon #houseofcomplements
Tweet media one
Tweet media two
3
6
13
@s_almutar
Sara Almutar
1 month
Building glomerular disease clinics workshop has started! Register and learn from the experts! Don’t miss it! @GlomCon .
2
4
14
@s_almutar
Sara Almutar
1 month
RT @edgarvlermamd: Sibeprenlimab Halves uPCR in IgA Nephropathy (IgAN) Trial from @VladoPerkovic @Medscape.#ERA25 🇦🇹 #Nephpearls . https://….
0
38
0
@s_almutar
Sara Almutar
1 month
RT @ERAkidney: Last presentation during LBCTII #ERA25 . 📍Mineralocorticoid receptor antagonists in patients with kidney failure receiving d….
0
6
0
@s_almutar
Sara Almutar
1 month
RT @NephroSeeker: Michael Walsh presenting ACHIEVE trial during #ERA25. 🤩 super interesting methodology published 2 days ago (still countin….
0
5
0
@s_almutar
Sara Almutar
1 month
RT @ERAkidney: 🌶️🌶️🌶️. #ERA25 #LBCT . 51% reduction in proteinuria at 9 months!. 🌶️🌶️🌶️.
0
4
0
@s_almutar
Sara Almutar
1 month
It’s so lovely to finally meet in person at #ERA25 🥰 @GlomCon @ERAkidney @SaynaNorouzi
Tweet media one
1
1
20
@s_almutar
Sara Almutar
1 month
RT @NEJM: Presented at #ERA25: . In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy wi….
0
130
0
@s_almutar
Sara Almutar
1 month
Kicking off day 1 of the #ERA2025 congress in Vienna with great sessions and lots of learning!.#BeyondNephrology
Tweet media one
Tweet media two
Tweet media three
Tweet media four
0
1
6
@s_almutar
Sara Almutar
2 months
RT @hjanders_hans: Now open access in the June edition of @NDTsocial. Disease-modifying anti-nephropathic drugs (DMANDs)—a definition propo….
0
20
0
@s_almutar
Sara Almutar
2 months
RT @odlerb: ANCA-negative pauci-immune glomerulonephritis must be one of the most challenging fields in vasculitis. In this commentary in @….
0
16
0
@s_almutar
Sara Almutar
2 months
RT @edgarvlermamd: Fast forward to 2025 ⏩ Long-term Outcome of Adult Patients with Membranous Nephropathy treated with Rituximab from @KIRe….
0
14
0
@s_almutar
Sara Almutar
2 months
RT @LadanZand: The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy….
0
41
0
@s_almutar
Sara Almutar
2 months
RT @gunnar_heine: Lupus weeks @MarkusAtHome:. Tonight 7:30 CEST (and later on demand) @BradRovin Dr. Ana Malvar.REGENCY. Next Friday 7:30 C….
0
7
0
@s_almutar
Sara Almutar
2 months
RT @GlomCon: Join GlomCon on May 11, Sunday. Targeted Disease Modification in IgA Nephropathy by Dr. Jonathan Barratt @IgAN_JBarratt . ID:….
0
18
0
@s_almutar
Sara Almutar
3 months
RT @SaynaNorouzi: ⭐️Such overwhelming interest in the upcoming workshop – "How to Build a Glomerular Disease Clinic: A Step Towards a Cente….
0
18
0
@s_almutar
Sara Almutar
3 months
RT @SaynaNorouzi: Smoking-modified HTN-associated nodular glomerulosclerosis (SHaNGS), a form of hypertensive glomerulosclerosis in the con….
0
18
0
@s_almutar
Sara Almutar
4 months
RT @JasmineNephro: 😎Management of Nephrotic syndrome using anti nephrin antibodies 🔜. @NDTsocial @hjanders_hans . h….
0
53
0